About Dendreon

Dendreon (NASDAQ: DNDN) was a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), was an immunotherapy for prostate cancer.–Wikipedia

Reviews

Overall

3.5
Based on 94 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
3.3
Compensation/Benefits
4.1
Job Security/Advancement
2.5
Management
2.7
Culture
3.3

Salaries

10 salaries reported
$47,412 per year
  • Most Reported
$20,000
$93,000
5 salaries reported
$60,635 per year
$20,000
$93,000
4 salaries reported
$45,408 per year
Min and max salaries are hidden when we have fewer than 5 salaries
Claimed Profile
Headquarters
Russell Investments Center, Seattle
Links
Dendreon website